journal article·2014-11

Synthesis and evaluation of ciprofloxacin-loaded carboxymethyl tamarind kernel polysaccharide nanoparticles

Neeraj Dilbaghi, Harmanmeet Kaur, Munish Ahuja, Pooja Arora, Sandeep Kumar

Publisher page

Abstract

Nanotechnology is currently employed as a tool to fight more efficiently against human pathogens. Nanoparticles can be prepared from a variety of materials such as protein, biodegradable polymers and synthetic polymers. Tamarindus indica Linn. or tamarind is one of the most important biodegradable polymer. In the present study, chemically modified polymer of tamarind ‘carboxymethyl tamarind kernel polysaccharide’ (CMTKP) is used for the synthesis of nanoparticulate formulation. Antibacterial activity of CMTKP was analysed which was then enhanced by incorporating a flouroquinolone antibiotic, ciprofloxacin to it. Ciprofloxacin-loaded CMTKP nanoparticles were synthesised via ionotropic gelation technique. Nanosuspension so formed was lyophilised by addition of a cryoprotectant. Nanoparticles obtained were characterised for its particle size, morphology and stability. Interaction studies were confirmed by Fourier transform infrared spectroscopy (FT-IR). Antibacterial activities of ciprofloxacin, CMTKP and ciprofloxacin-loaded CMTKP nanoparticles were tested against two Gram negative and positive bacteria. The antibacterial assay results revealed greatest zone of inhibition by ciprofloxacin-loaded CMTKP nanoparticles in Micrococcus luteus. Toxicity analysis of the prepared formulation was carried out on vero cell lines via resazurin assay which revealed its minimum toxicity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Nanocomposite Films for Food Packaging · Phytochemicals and Medicinal Plants

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (21)

Show source-provided references
1. 10.1016/S1359-6446(03)02903-910.1016/S1359-6446(03)02903-9 ↗
2. Racovita S. · Rev Roum Chim · 2009 · 54 · 709
3. 10.1016/j.carbpol.2009.09.01410.1016/j.carbpol.2009.09.014 ↗
4. 10.1073/pnas.060175510310.1073/pnas.0601755103 ↗
5. 10.1021/la020237410.1021/la0202374 ↗
6. 10.1016/j.jcis.2004.02.01210.1016/j.jcis.2004.02.012 ↗
7. 10.1021/jp063826h10.1021/jp063826h ↗
8. 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
9. 10.1166/jnn.2005.03410.1166/jnn.2005.034 ↗
10. 10.1086/51236910.1086/512369 ↗
11. Kawahara S · Nippon Rinsho · 1998 · 56 · 3096
12. 10.1080/1040839060094860010.1080/10408390600948600 ↗
13. Khanna M · Indian Drugs · 1997 · 24 · 268
14. 10.3797/scipharm.0908-1010.3797/scipharm.0908-10 ↗
15. Kaur H · Int J Biol Macromol. · 2011 · 833
16. 10.1021/jp063826h10.1021/jp063826h ↗
17. Wilson A P. · 2000 · 17510.1093/oso/9780199637973.003.0007 ↗
18. 10.1155/2012/20260810.1155/2012/202608 ↗
19. 10.5185/amlett.2012.534210.5185/amlett.2012.5342 ↗
20. 10.1126/science.111439710.1126/science.1114397 ↗
21. 10.1016/j.jaerosci.2011.06.00510.1016/j.jaerosci.2011.06.005 ↗